Last reviewed · How we verify

NCT02215915: ULTIMATE

Intravascular Ultrasound Guided Drug Eluting Stents Implantation in "All-comers" Coronary Lesions (ULTIMATE Trial)

Completed NA Last updated 3 November 2020
What this trial tests

NA trial testing Angiography in Coronary Artery Disease in 1,448 participants. Completed in 30 October 2020.

Timeline
1 August 2014
Primary endpoint
30 May 2017
30 October 2020

Quick facts

Lead sponsorNanjing First Hospital, Nanjing Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment1,448
Start date1 August 2014
Primary completion30 May 2017
Estimated completion30 October 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Nanjing First Hospital, Nanjing Medical University

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A number of 1448 patients scheduled for elective percutaneous coronary intervention (PCI) with a native coronary stenosis suitable for DES implantation and IVUS imaging are openly randomized 1:1 to either IVUS guidance or angiographic guidance groups.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.
    Zhang J, Gao X, Kan J, Ge Z, et al · · 2018 · cited 420× · PMID 30261237 · DOI 10.1016/j.jacc.2018.09.013
  2. 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation.
    Gao XF, Ge Z, Kong XQ, Kan J, et al · · 2021 · cited 220× · PMID 33541535 · DOI 10.1016/j.jcin.2020.10.001
  3. Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: Results from ULTIMATE trial.
    Zhang J, Gao X, Ge Z, Han L, et al · · 2019 · cited 14× · PMID 31116913 · DOI 10.1002/ccd.28308
  4. Procedural Characteristics of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention and Their Clinical Implications.
    Lee SY, Zhang JJ, Mintz GS, Hong SJ, et al · · 2022 · cited 8× · PMID 35861828 · DOI 10.1161/jaha.122.025258
  5. Sex Differences in Cardiovascular Outcomes of Intravascular Imaging-Guided PCI: A Meta-Analysis of Randomized Controlled Trials.
    Ezenna C, Ibrahim S, Ramesh P, Ismayl M, et al · · 2025 · cited 3× · PMID 40829371 · DOI 10.1016/j.jacadv.2025.102076
  6. Intravascular imaging-guided versus coronary angiography-guided percutaneous coronary intervention: Meta-analysis and trial sequential analysis of randomized controlled trials.
    Li X, Zhong D, Yin Z, Liu H, et al · · 2026 · PMID 41686557 · DOI 10.1097/md.0000000000047193

Verify or expand the search:

Other trials of Angiography

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Nanjing First Hospital, Nanjing Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02215915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing